Showing results (1-10 of 121) with videos related to
Sort By:
Pageof 13
Hamostaseologie|August 9, 2011
Treatment and secondary prevention of venous thromboembolism in cancer patients. Current strategies and new therapeutic optionsC Ay, I PabingerHamostaseologie|August 9, 2011
Risk of venous thromboembolism and primary prophylaxis in cancer. Should all patients receive thromboprophylaxis?I Pabinger, C AyHamostaseologie|March 6, 2015
VTE risk assessment in cancer. Who needs prophylaxis and who does not?C Ay, I PabingerHamostaseologie|July 28, 2011
Clinical significance of circulating microparticles for venous thromboembolism in cancer patientsJ Thaler, C Ay, I PabingerAnnals of Oncology : Official Journal of the European Society for Medical Oncology|March 29, 2019
Treatment of cancer-associated venous thromboembolism in the age of direct oral anticoagulantsC Ay, J Beyer-Westendorf, I PabingerJournal of Thrombosis and Haemostasis : JTH|May 20, 2015
Venous thrombosis and cancer: from mouse models to clinical trialsY Hisada, J E Geddings, C Ay, et al.Journal of Thrombosis and Haemostasis : JTH|July 6, 2017
Factor XI-deficient mice exhibit increased bleeding after injury to the saphenous veinC Ay, Y Hisada, B C Cooley, et al.Journal of Thrombosis and Haemostasis : JTH|December 23, 2014
Estimating risk of venous thromboembolism in patients with cancer in the presence of competing mortalityC Ay, F Posch, A Kaider, et al.Applied Microbiology|January 1, 1971
Modification of the American Public Health Association procedure for counting yeast and mold in cottage cheeseE M Powers, C C Ay, G A Eckfeldt, et al.Pageof 13